Pancreatic Cancer Research

ResearcherMedical University of ViennaActive in the last 2 years

Gerhard Hamilton

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4038-5182; OpenAlex author ID A5019973974. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

  1. Targeting KRAS in pancreatic cancer. Last author DOI 10.32604/or.2024.045356↗
  2. Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell lines. Last author DOI 10.1007/s12672-022-00550-w↗
  3. Dependence of Relative Expression of NTR1 and EGFR on Cell Density and Extracellular pH in Human Pancreatic Cancer Cell Lines. First author DOI 10.3390/cancers3010182↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sandra Stickler · 2 shared papers, 2022–2024 · strength 0.53
  2. Adelina Plangger · 1 shared paper, 2022 · strength 0.16
  3. Ulrike Olszewski · 1 shared paper, 2011 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.